Dimensional Fund Advisors
SGMT icon

Dimensional Fund Advisors’s Sagimet Biosciences SGMT Stock Holding History

Dimensional Fund Advisors’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
397,972
+126,755
+47% +$862K ﹤0.01% 2637
2026
Q1 		$1.41M Buy
271,217
+135,178
+99% +$753K ﹤0.01% 2774
2025
Q4 		$805K Buy
136,039
+110,705
+437% +$795K ﹤0.01% 2893
2025
Q3 		$174K Hold
25,334
– – ﹤0.01% 3135
2025
Q2 		$193K Hold
25,334
– – ﹤0.01% 3120
2025
Q1 		$82.7K Hold
25,334
– – ﹤0.01% 3221
2024
Q4 		$114K Buy
+25,334
New +$128K ﹤0.01% 3229

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Dimensional Fund Advisors's SGMT Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Sagimet Biosciences (SGMT) stake by 47% in Q2 2026, buying an estimated $862K and bringing the position to 397,972 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

Dimensional Fund Advisors first reported a position in SGMT in Q4 2024 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Dimensional Fund Advisors held 397,972 shares of Sagimet Biosciences worth $3.08M as of Q2 2026.
  • Dimensional Fund Advisors bought 126,755 Sagimet Biosciences shares in Q2 2026, an estimated $862K.
  • Sagimet Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2637 holding.
  • Dimensional Fund Advisors first reported a position in Sagimet Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.